Lidocaine Hydrochloride and Epinephrine
- Product NDC
- 52584-177
- 11-digit product format
- 525840177
- Labeler code
- 52584
- Product ID
- 52584-177_6930bae4-93a8-4daa-8267-128e3cd6421b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lidocaine Hydrochloride and Epinephrine
- Dosage form
- INJECTION, SOLUTION
- Route
- INFILTRATION; PERINEURAL
- Labeler
- General Injectables & Vaccines, Inc
- Application
- ANDA089635
- Marketing category
- ANDA
- Marketing start
- 2019-09-23
- Marketing end
- 2023-05-01
- Substance
- EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
- Active strength
- 5 ug/mL; mg/mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 52584-177-01 | 52584017701 | 1 VIAL, MULTI-DOSE in 1 BAG (52584-177-01) > 50 mL in 1 VIAL, MULTI-DOSE | 2019-09-23 | 2023-05-01 | No | No | Current |